Bing Han

8PUBLICATIONS
3CO-AUTHORS
Regenerative medicine (incl. stem cells)Cardiovascular medicine and haematology not elsewhere classifiedRespiratory diseasesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 19, 2025
Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study.

Xijuan Lin, Chen Yang, Ziwei Liu

|Nov 12, 2024
Cyclosporine plus avatrombopag versus cyclosporine monotherapy for first-line treatment of elderly patients with transfusion-dependent non-severe aplastic anemia: a single center retrospective study.

Zhuxin Zhang, Qinglin Hu, Leyu Wang

|Jan 01, 2024
COVID-19 vaccination prevents a more severe course and treatment with complement inhibitors reduce worsening hemolysis during the Omicron pandemic in patients with PNH: a single-center study.

Leyu Wang, Qinglin Hu, Yuan Yang

|Nov 15, 2023
Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study.

Zhuxin Zhang, Qinglin Hu, Chen Yang

|Jun 24, 2022
Dose of deferasirox correlates with its effects, which differ between low-risk myelodysplastic syndrome and aplastic anaemia.

Ruoxi Zhang, Bing Han

|Mar 08, 2022
Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.

Yuzhou Huang, Miao Chen, Chen Yang

Pageof 2

Frequent Collaborators

1 joint publications

Ruoxi Zhang

1 joint publications

Xijuan Lin

1 joint publications

Junling Zhuang